$
₹
$2.23—% (+2.23)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
1D
1W
1M
1Y
5Y
Max
Key Metrics
Key Metrics
PE TTM
PE TTM
Close price divided by the earnings per share for the trailing twelve months
—
PB
PB
Close price divided by the book value per share at the end of the most recent quarter
0
EPS TTM
EPS TTM
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
$-0.21
PEG Ratio
PEG Ratio
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
—
Profit Margin
Profit Margin
Net profit divided by the total revenue for the most recent financial year
0%
Dividend Yield
Dividend Yield
Annual dividend per share for the trailing twelve months divided by the close price
—
Company Profile
Peers
Peers
ABBV
P/E Ratio
108.62
108.62
1Y Return
18.41%
18.41%
Buy Reco %
57.14
57.14
AMGN
P/E Ratio
24.39
24.39
1Y Return
19.48%
19.48%
Buy Reco %
46.87
46.87
P/E Ratio
16.91
16.91
1Y Return
15.59%
15.59%
Buy Reco %
63.33
63.33
P/E Ratio
26.73
26.73
1Y Return
3.84%
3.84%
Buy Reco %
52.94
52.94
P/E Ratio
15.01
15.01
1Y Return
17.93%
17.93%
Buy Reco %
76.00
76.00
Peers & Comparison
Peers & Comparison
Valuation
Returns
Forecast
| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| Vyome Holdings, Inc. | - | 0 | - |
| AbbVie Inc | 108.62 | 50.45 | 0.61 |
| Amgen Inc | 24.39 | 20.58 | 2.31 |
Price Comparison
Price Comparison
1 Month
1 Year
5 Years
Financials
Financials
Income
Balance Sheet
Cash Flow
Quarterly Normal View
Hmm, looks like data is currently unavailable. Once it's updated, you can view it here
